Total Payments
$78,260
2023 Payments
$2,988
Companies
15
Transactions
88
Payment Breakdown by Category
Consulting$53,611 (68.5%)
Other$11,605 (14.8%)
Travel$8,583 (11.0%)
Food & Beverage$2,267 (2.9%)
Research$2,194 (2.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $53,611 | 18 | 68.5% |
| Travel and Lodging | $8,583 | 29 | 11.0% |
| Grant | $6,205 | 4 | 7.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,750 | 2 | 4.8% |
| Food and Beverage | $2,267 | 32 | 2.9% |
| Unspecified | $2,194 | 1 | 2.8% |
| Honoraria | $1,650 | 2 | 2.1% |
Payments by Type
General
$76,066
87 transactions
Research
$2,194
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $20,617 | 10 | $0 (2023) |
| Dova Pharmaceuticals | $14,873 | 7 | $0 (2021) |
| Bayer HealthCare Pharmaceuticals Inc. | $6,235 | 12 | $0 (2017) |
| Novo Nordisk Inc | $6,205 | 4 | $0 (2023) |
| Shionogi Inc | $4,658 | 5 | $0 (2018) |
| Sysmex America, Inc. | $4,388 | 11 | $0 (2017) |
| GENZYME CORPORATION | $4,298 | 3 | $0 (2022) |
| Rigel Pharmaceuticals, Inc. | $4,093 | 4 | $0 (2020) |
| Kedrion Biopharma Inc. | $3,737 | 3 | $0 (2018) |
| Janssen Research & Development, LLC | $3,582 | 11 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $2,988 | 4 | Janssen Research & Development, LLC ($2,100) |
| 2022 | $9,082 | 13 | GENZYME CORPORATION ($4,298) |
| 2021 | $13,304 | 7 | Dova Pharmaceuticals ($6,680) |
| 2020 | $11,020 | 4 | Novartis Pharmaceuticals Corporation ($7,270) |
| 2019 | $10,849 | 9 | Dova Pharmaceuticals ($5,193) |
| 2018 | $11,358 | 22 | Shionogi Inc ($4,658) |
| 2017 | $19,659 | 29 | Novartis Pharmaceuticals Corporation ($9,036) |
All Payment Transactions
88 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/17/2023 | Novo Nordisk Inc | — | Grant | Cash or cash equivalent | $847.62 | General |
| 08/17/2023 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| 07/22/2023 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $40.60 | General |
| Category: Oncology | ||||||
| 01/09/2023 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| 12/09/2022 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 11/04/2022 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 11/04/2022 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $40.00 | General |
| 11/04/2022 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $40.00 | General |
| 11/04/2022 | Janssen Research & Development, LLC | — | Food and Beverage | Cash or cash equivalent | $33.42 | General |
| 11/03/2022 | Janssen Research & Development, LLC | — | Travel and Lodging | In-kind items and services | $738.18 | General |
| 11/03/2022 | Janssen Research & Development, LLC | — | Travel and Lodging | In-kind items and services | $278.10 | General |
| 11/03/2022 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $150.00 | General |
| 11/03/2022 | Janssen Research & Development, LLC | — | Travel and Lodging | Cash or cash equivalent | $135.60 | General |
| 11/03/2022 | Janssen Research & Development, LLC | — | Travel and Lodging | Cash or cash equivalent | $6.75 | General |
| 09/06/2022 | Novo Nordisk Inc | — | Grant | Cash or cash equivalent | $3,301.60 | General |
| 06/08/2022 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $749.00 | General |
| 03/27/2022 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $3,499.00 | General |
| 12/31/2021 | Novo Nordisk Inc | — | Grant | Cash or cash equivalent | $342.71 | General |
| 12/15/2021 | Dova Pharmaceuticals | Doptelet (Drug) | Consulting Fee | Cash or cash equivalent | $3,080.00 | General |
| Category: Hematology/Oncology | ||||||
| 11/30/2021 | Novo Nordisk Inc | — | Grant | Cash or cash equivalent | $1,713.55 | General |
| 09/01/2021 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Consulting Fee | Cash or cash equivalent | $4,270.00 | General |
| Category: ONCOLOGY | ||||||
| 07/23/2021 | Galderma Laboratories, L.P. | AKLIEF (Drug), EPIDUO FORTE, ORACEA | Food and Beverage | In-kind items and services | $147.49 | General |
| Category: ACNE | ||||||
| 02/23/2021 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Honoraria | Cash or cash equivalent | $150.00 | General |
| Category: Immunology | ||||||
| 02/18/2021 | Dova Pharmaceuticals | Doptelet (Drug) | Consulting Fee | Cash or cash equivalent | $3,600.00 | General |
| Category: Hematology/Oncology | ||||||
| 12/28/2020 | Rigel Pharmaceuticals, Inc. | Tavalisse (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Hematology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| NGAM-10 | Octapharma USA, Inc. | $2,194 | 1 |
About Dr. Michele Lambert, M.D
Dr. Michele Lambert, M.D is a Pediatrics healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407886807.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michele Lambert, M.D has received a total of $78,260 in payments from pharmaceutical and medical device companies, with $2,988 received in 2023. These payments were reported across 88 transactions from 15 companies. The most common payment nature is "Consulting Fee" ($53,611).
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Pediatric Hematology-Oncology
- Location Philadelphia, PA
- Active Since 07/03/2006
- Last Updated 04/15/2013
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1407886807
Products in Payments
- PROMACTA (Drug) $20,617
- Doptelet (Drug) $14,873
- Kovaltry (Drug) $6,235
- Mulpleta (Drug) $4,658
- XN Series (Device) $4,388
- Tavalisse (Drug) $4,093
- Koate (Biological) $3,737
- PANZYGA (Biological) $2,194
- Nplate (Biological) $1,769
- BRILINTA (Drug) $1,312
- Soliris (Drug) $150.00
- AKLIEF (Drug) $147.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Philadelphia
Matthew Gillespie, M.d, M.D
Pediatrics — Payments: $1.5M
Pediatrics $1.5M
Stephan Grupp, M.d, M.D
Pediatrics — Payments: $472,209
Pediatrics $472,209
Oscar Mayer, M.d, M.D
Pediatrics — Payments: $270,148
Pediatrics $270,148
Robert Shaddy, Md, MD
Pediatrics — Payments: $148,516
Pediatrics $148,516
Michael Levine, Md, MD
Pediatrics — Payments: $137,530
Pediatrics $137,530
Michael Grunstein, M.d, M.D
Pediatrics — Payments: $133,646
Pediatrics $133,646